Chromatin Receives $23,550,000 New Funding Round

  • Feed Type
  • Date
    12/10/2013
  • Company Name
    Chromatin
  • Mailing Address
    10 South LaSalle Street Chicago, IL 60603
  • Company Description
    Chromatin’s proprietary mini-chromosome technology can rapidly deliver multi-gene clusters designed to ensure stable and consistent gene expression in plants.
  • Website
    http://www.chromatininc.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $23,550,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy